Please login to the form below

Not currently logged in


This page shows the latest Erelzi news and features for those working in and with pharma, biotech and healthcare.

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case

The US supreme court has decided not to review a patent case brought forward by Novartis’ generics division Sandoz for its Enbrel biosimilar Erelzi. ... Erelzi references Amgen’s blockbuster arthritis drug Enbrel (etanercept) – Sandoz had been

Latest news

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...